Cite
Magbanua MJM, Li W, Wolf DM, et al. Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk. NPJ Breast Cancer. 2021;7(1):32doi: 10.1038/s41523-021-00239-3.
Magbanua, M. J. M., Li, W., Wolf, D. M., Yau, C., Hirst, G. L., Swigart, L. B., Newitt, D. C., Gibbs, J., Delson, A. L., Kalashnikova, E., Aleshin, A., Zimmermann, B., Chien, A. J., Tripathy, D., Esserman, L., Hylton, N., van 't Veer, L., Prakash, D., Jain, S., & Chauhan, K. (2021). Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk. NPJ breast cancer, 7(1), 32. https://doi.org/10.1038/s41523-021-00239-3
Magbanua, Mark Jesus M, et al. "Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk." NPJ breast cancer vol. 7,1 (2021): 32. doi: https://doi.org/10.1038/s41523-021-00239-3
Magbanua MJM, Li W, Wolf DM, Yau C, Hirst GL, Swigart LB, Newitt DC, Gibbs J, Delson AL, Kalashnikova E, Aleshin A, Zimmermann B, Chien AJ, Tripathy D, Esserman L, Hylton N, van 't Veer L, Prakash D, Jain S, Chauhan K. Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk. NPJ Breast Cancer. 2021 Mar 25;7(1):32. doi: 10.1038/s41523-021-00239-3. PMID: 33767190; PMCID: PMC7994408.
Copy
Download .nbib